The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.
暂无分享，去创建一个
O. Lambotte | S. Champiat | A. Marabelle | C. Massard | J. Michot | C. Baldini | A. Laparra | S. Laghouati | A. Voisin | F. Danlos | S. Messayke | P. Romano-Martin | V. Goldschmidt | Valentine Ruste | Ariane Laparra | Sabine Messayke